WHO ICTRP trial
Effect of a Platelet Rich Plasma (PRP) injection on the outcome of chronic…
NL-OMON40290 · Overview of Medical Research in the Netherlands (NL-OMON)
Key facts
| Trial ID | NL-OMON40290 |
|---|---|
| Public title | Effect of a Platelet Rich Plasma (PRP) injection on the outcome of chronic lateral epicondylitis. A double blinded randomized controlled clinical trial. |
| Scientific title | Effect of a Platelet Rich Plasma (PRP) injection on the outcome of chronic lateral epicondylitis. A double blinded randomized controlled clinical trial. - Effect of a PRP injection on chronic lateral epicondylitis. |
| Primary sponsor | Ziekenhuisvoorzieningen Gelderse Vallei |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Lateral epicondylitis Tenniselbow;10001316;10043237;10040795;Lateral epicondylitis;Tenniselbow |
| Interventions | 27 ml of whole blood will be taken from the cubital vein of each patient, three ml of citrate will be added to prevent the blood from clotting. If the patient is randomized to the PRP injection group, the collected blood is centrifuged for… |
| Registration date | Dec 23, 2014 |
| Target size | 60 |
| Secondary IDs | NL44980.041.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: